¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Current gene therapy."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • radiation therapy
    ¹æ»ç¼±Ä¡·á, ¹æ»ç¼±¿ä¹ý
  • replacement therapy
    ´ëÄ¡¿ä¹ý
  • speech therapy
    ¾ð¾îÄ¡·á
  • supportive therapy
    ÁöÁö¿ä¹ý
  • symptomatic therapy
    ´ëÁõ¿ä¹ý
  • systemic therapy
    Àü½Å¿ä¹ý
  • ultrasonic therapy
    ÃÊÀ½ÆÄ¿ä¹ý
  • ultrasound therapy
    ÃÊÀ½ÆÄ¿ä¹ý
  • vaccine therapy
    ¹é½Å¿ä¹ý
  • will therapy
    ÀÇÁö¿ä¹ý
  • autosomal gene
    º¸Åë¿°»öüÀ¯ÀüÀÚ
  • additive gene
    »ó°¡À¯ÀüÀÚ
  • allelic gene
    ´ë¸³À¯ÀüÀÚ
  • complementary gene
    º¸Á·À¯ÀüÀÚ, »óÈ£º¸ÃæÀ¯ÀüÀÚ
  • control gene
    Á¦¾îÀ¯ÀüÀÚ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • mutant gene
    µ¹¿¬º¯ÀÌÀ¯ÀüÀÚ
  • mutator gene
    º¯ÀÌÀ¯¹ßÀ¯ÀüÀÚ
  • nucleolar gene
    ÇÙ¼ÒüÀ¯ÀüÀÚ
  • operator gene
    ÀÛµ¿À¯ÀüÀÚ
  • recessive gene
    ¿­¼ºÀ¯ÀüÀÚ
  • regulator gene
    Á¶ÀýÀ¯ÀüÀÚ
  • reporter gene
    Á¤º¸Á¦°øÀ¯ÀüÀÚ
  • repressor gene
    ¾ïÁ¦À¯ÀüÀÚ
  • retinoblastoma gene
    ¸Á¸·¸ð¼¼Æ÷Á¾À¯ÀüÀÚ
  • structural gene
    ±¸Á¶À¯ÀüÀÚ
  • suicide gene
    ÀÚ»ìÀ¯ÀüÀÚ
  • supressor gene
    ¾ïÁ¦À¯ÀüÀÚ
  • tumor suppressor gene
    Á¾¾ç¾ïÁ¦À¯ÀüÀÚ
  • single major gene locus model
    ´ÜÀÏÁÖ¿äÀ¯ÀüÀÚÀÚ¸®¸ðÇü
  • activity therapy
    Ȱµ¿¿ä¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • antifungal therapy
    Ç×°õÆÎÀÌÄ¡·á
  • antimicrobial therapy
    Ç×±Õ¿ä¹ý(ù÷жèþÛö).
  • art therapy
    ¿¹¼ú¿ä¹ý
  • fractionated stereotactic radiation therapy
    ºÐÇÒÁ¤À§ ¹æ»ç¼±Ä¡·á
  • gold therapy
    ±Ý Ä¡·á
  • gonadotropin therapy
    ¼º¼±ÀÚ±ØÈ£¸£¸ó¿ä¹ý.
  • grenz-ray therapy
    ±×·£Â꼱ġ·á
  • health resort therapy
    ÀüÁö¿ä¹ý(ÊÙËíËÑ).
  • heparin therapy monitoring
    ÇìÆÄ¸°¿ä¹ý<--Ä¡·á>°¨½Ã
  • hyperbaric oxygen therapy
    °í¾Ð»ê¼Ò¿ä¹ý
  • hyperbaric oxygenation therapy
    °í¾Ð»ê¼Ò¿ä¹ý(ÍÔäâß«áÈèþÛö)
  • immunization therapy
    ¸é¿ª¿ä¹ý(Øóæ¹èþÛö).
  • immunization therapy
    ¸é¿ª¿ä¹ý(¸é¿ª¿ä¹ý).
  • immunosuppressive therapy
    ¸é¿ª¾ïÁ¦¿ä¹ý(¡­åäð¤èþÛö).
  • immunosuppressive therapy
    ¸é¿ª¾ïÁ¦¿ä¹ý
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • exaggeration gene
    °­Á¶À¯ÀüÀÚ(¡­ë¶îîí­).
  • familial colon carcinoma gene
    °¡Á·¼º ´ëÀå¾ÏÁ¾ À¯ÀüÀÚ
  • fmr-1 gene
    FMR-1 À¯ÀüÀÚ
  • gene
    À¯ÀüÀÚ(ë¶îîí­)
  • gene
    À¯Àü(ÀÎ)ÀÚ(ë¶îîì×í­).
  • gene
    À¯ÀüÀÚ
  • gene amplification
    À¯ÀüÀÚÁõÆø
  • gene amplification
    À¯ÀüÀÚ ÁõÆø
  • gene analyses
    À¯ÀüÀںм®
  • gene analysis
    À¯ÀüÀںм®(¡­ÝÂà°).
  • gene analysis
    À¯ÀüÀںм®.
  • gene cloning
    À¯ÀüÀÚŬ·Î´×
  • gene conversion
    À¯ÀüÀÚº¯È¯(ܨüµ).
  • gene conversion
    À¯ÀüÀÚÀüȯ.
  • gene conversion
    À¯ÀüÀÚÀüȯ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • MIT gene
    MIT À¯ÀüÀÚ(ë¶îîí­)
  • modification gene
    ¼ö½ÄÈ¿¼Ò À¯ÀüÀÚ(áóãÞý£áÈë¶îîí­)
  • modifying gene
    ¼ö½ÄÀ¯ÀüÀÚ(áóãÞë¶îîí­)
  • morphogenetic gene
    ÇüÅÂÇü¼ºÀ¯ÀüÀÚ(û¡÷¾û¡à÷ë¶îîí­)
  • morphopoietic gene
    ÇüÅÂÀ¯ÀüÀÚ(û¡÷¾ë¶îîí­)
  • multiple gene
    ´ÙÀ¯ÀüÀÚ(Òýë¶îîí­)
  • mutable gene
    °¡º¯ÀÌÀ¯ÀüÀÚ(ʦܨì¶ë¶îîí­)
  • mutant gene
    º¯ÀÌÀ¯ÀüÀÚ(ܨì¶ë¶îîí­)
  • mutator gene
    º¯ÀÌÀÚ À¯ÀüÀÚ(ܨì¶í­ë¶îîí­)
  • negative gene control
    À½À¯ÀüÀÚÁ¦¾î(ëäë¶îîí­ð¤åÙ)
  • nif gene
    nif À¯ÀüÀÚ(ë¶îîí­)
  • nonessential gene
    ºñÇʼöÀ¯ÀüÀÚ(Þªù±áóë¶îîí­)
  • one-gene-one-enzyme hypothesis
    ÀÏÀ¯ÀüÀÚÀÏÈ¿¼Ò¼³(ìéë¶îîí­ìéý£áÈàã)
  • one-gene-one-polypeptide chain hypothesis
    ÀÏÀ¯ÀüÀÚ(ìéë¶îîí­) ÀÏ(ìé)Æú¸®ÆéŸÀÌµå »ç½½¼³(àã)
  • open gene
    ¿­¸° À¯ÀüÀÚ(ë¶îîí­)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
CLML Current List of Medical Literature
CMIT Current Medical Information and Terminology
CP candle power; capillary pressure; cardiac pacing; cardiac performance; cardiopulmonary; caudate puta...
CPF clot-promoting factor; complication probability factor; contraction peak force; current patient file...
CPS carbamoylphosphate synthetase; cardioplegic perfusion solution; centipoise; cervical pain syndrome; ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
MPSC miniature postsynaptic current
p.s.c. post-synaptic current
SCD Scalp current density
SCC Short circuit current
STOC spontaneous transient outward current
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • indirect pulp therapy
    °£Á¢ Ä¡¼ö Ä¡·á
  • infrared laser therapy
    Àû¿Ü¼± ·¹ÀÌÀú ¿ä¹ý
    µ¿ÀǾî=cold laser thera
  • initial therapy
    Ãʱâ Ä¡·á
  • insulin convulsive therapy combined
    Àν¶¸° °æ·Ã º´ÇÕ Ä¡·á, Àν¶¸° °æ·Ã º´ÇÕ ¿ä¹ý
  • irreversible occlusal therapy
    ºñ°¡¿ªÀûÀÎ ±³ÇÕ Ä¡·á, ºñ°¡¿ªÀû ±³ÇÕ Ä¡·á
  • laser therapy
    ·¹ÀÌÀú Ä¡·á
    ÁÖ·Î ÃâÇ÷ÀÌ Àû¾î¾ß Çϰųª µ¿ÅëÀÌ ½ÉÇÑ È¯ÀÚÀÇ ¼ö¼úÀ̳ª »óóÀÇ À¶ÇÕ, Á¶Á÷ÀÇ ÆÄ±« µî¿¡ »ç¿ëµÈ´Ù.
  • light therapy
    ±¤¼± Ä¡·á
  • microwave therapy
    ±ØÃÊ´ÜÆÄ ¿ä¹ý
    ÆÄÀå 1 m ÀÌÇÏ, 1 mm ÀÌ»óÀÇ ÀüÀÚÆÄ¸¦ ÀÌ¿ëÇÏ´Â Àü±â¿ä¹ý. ¸¶ÀÌÅ©·Î¿þÀÌºê ¿ä¹ý , ¸¶ÀÌÅ©·ÎÆÄ ¿ä¹ýÀ̶ó°íµµ ÇÑ´Ù. º¸Åë ÀÇ·á¿ë¿¡´Â 12.5 cmÀÇ ÆÄÀåÀÌ Ã¤¿ëµÇ°í ÀÖ´Ù. ¸¶±×³×Æ®·ÐÀ̶ó´Â Áø°ø°ü¿¡¼­ ¹ßÁøµÇ¾î ¹Ý¿øÇü ¶Ç´Â °¢ÇüÀÇ Á¶»ç ÀåÄ¡·Î 5~10 cmÀÇ °Å¸®¿¡¼­ ȯºÎ¸¦ Á¶»çÇÑ´Ù. ÀÎü¿¡ Á¶»çÇÏ¿´À» ¶§ 3~4 cm¿¡¼­ ´ëºÎºÐ Èí¼öµÇ°í, ±× ¿¡³ÊÁö´Â ¿­·Î º¯ÇÑ´Ù. Áï, ½É´Þ¼ºÀº ÃÊ´ÜÆÄº¸´Ù ÀÛ°í Àû¿Ü¼±º¸´Ù´Â Å©´Ù. ±×·¸°Ô ±íÁö ¾ÊÀº Á¶Á÷¿¡ ´ëÇÑ ¿Â¿­¿ä¹ýÀ¸·Î ¾²À̸ç, ³ú, ´«, °íȯ µî°ú °°ÀÌ Ç÷ÇàÀÌ ÀûÀº ±â°ü¿¡¼­´Â °ú¿­µÉ À§ÇèÀÌ ÀÖÀ¸¹Ç·Î Á¶»çÇÒ ¶§ ÁÖÀǰ¡ ÇÊ¿äÇÏ´Ù.
  • music therapy
    À½¾Ç ¿ä¹ý
  • non-reversible therapy
    ºñ°¡¿ªÀûÀÎ Ä¡·á
  • nonvital pulp therapy technique
    ½ÇȰ Ä¡¼ö Ä¡·á ¼ú½Ä
  • occlusal splint therapy
    ±³ÇÕ ÀåÄ¡ ¿ä¹ý
  • occlusal therapy
    ±³ÇÕ Ä¡·á
  • occupational therapy
    ÀÛ¾÷ ¿ä¹ý
    Ä¡·á ¸ñÀûÀ» À§ÇÑ ÀÛ¾÷ÀÇ Àû¿ë.
  • palliative therapy
    °í½ÄÀû Ä¡·á
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
photoradiation therapy Treatment of cancer by intravenous injection of a photosensitizing agent, such as haematoporphyrin, followed by exposure to visible light of superficial tumours or of deep tumours by a fibreoptic probe.
Synonym: photochemotherapy, photoradiation therapy.
(05 Mar 2000)
client-centreed therapy A system of nondirective psychotherapy based on the assumption that the client (patient) both has the internal resources to improve and is in the best position to resolve his or her own personality dysfunction, provided that the therapist can establish a permissive, accepting, and genuine atmosphere in which the client feels free to discuss problems and to obtain insight into them in order to achieve self-actualization.
(05 Mar 2000)
physical therapy A physical therapist is a specialist trained using exercise and physical activities to condition muscles and improve level of activity. Physical therapy is helpful in those with physical debilitating illness (for example stroke).
(27 Sep 1997)
physical therapy department, hospital Hospital department which is responsible for the administration and provision of diagnostic and medical rehabilitation services to restore or improve the functional capacity of the patient.
(12 Dec 1998)
cognitive therapy A direct form of psychotherapy based on the interpretation of situations (cognitive structure of experiences) that determine how an individual feels and behaves. It is based on the premise that cognition, the process of acquiring knowledge and forming beliefs, is a primary determinant of mood and behaviour. The therapy uses behavioural and verbal techniques to identify and correct negative thinking that is at the root of the aberrant behaviour.
(12 Dec 1998)
collapse therapy Surgical treatment of pulmonary tuberculosis whereby the lung is totally or partially, temporarily or permanently, immobilised. The procedure was based on the popular concept that collapsing the affected portion of a tuberculous lung allowed the infected area to rest and thereby recover. at the beginning of the 20th century artificially induced pneumothorax (pneumothorax, artificial) was popular. Later a variety of other techniques was used to encourage collapse of the infected portion of the lung: unilateral phrenic nerve division, pneumonolysis, pneumoperitoneum (pneumoperitoneum, artificial), and thoracoplasty. Collapse therapy has declined since the advent of antitubercular chemotherapy.
(12 Dec 1998)
colour therapy A form of phototherapy using colour to influence health and to treat various physical or mental disorders. The colour rays may be in the visible or invisible spectrum and can be administered through coloured lights or applied mentally through suggestion.
(12 Dec 1998)
combined modality therapy <oncology> Two or more types of treatments used to supplement each other.
For instance, surgery, radiation, chemotherapy, hormonal or immunotherapy may be used alternatively or together for maximum effectiveness.
(09 Oct 1997)
motion therapy, continuous passive Movement of a body part initiated and maintained by a mechanical or electrical device to restore normal range of motion to joints, muscles, or tendons after surgery, prosthesis implantation, contracture flexion, or long immobilization.
(12 Dec 1998)
plasma therapy Treatment with plasma.
(05 Mar 2000)
mud therapy The therapeutic use of mud in packs or baths. It includes mud, earth, clay, and peat. The original mud was fango, a volcanic mud from the battaglia thermal springs in italy, applied externally in the treatment of rheumatism and other diseases of the joints and muscles.
(12 Dec 1998)
play therapy A treatment technique utilizing play as a medium for expression and communication between patient and therapist.
(12 Dec 1998)
conditioning therapy The application of modern theories of learning and conditioning in the treatment of behaviour disorders.
(12 Dec 1998)
conjoint therapy A type of therapy in which a therapist sees the two spouses, or parent and child, or other partners together in joint sessions.
(05 Mar 2000)
convulsive therapy The use of convulsive agents to influence favourably the course of a mental disorder. It is used primarily in the treatment of severe affective disorders and schizophrenia.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á